Prothena Corporation plc (PRTA) Q4 2022 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Prothena Corporation Plc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:04.211 Good afternoon. My name is Audra, and I will be your conference operator today. 00:00:04.211 -- 00:00:08.534 At this time, I would like to welcome everyone to the Prothena Corporation fourth quarter 00:00:08.534 -- 00:00:12.436 and full year 2022 financial results conference call. 00:00:12.436 -- 00:00:15.278 There will be a question and answer session to follow. 00:00:15.278 -- 00:00:19.640 Please be advised that this call is being recorded at the company's request. 00:00:19.640 -- 00:00:21.281 I would now like to turn the call over to Mr. 00:00:21.281 -- 00:00:25.904 Eric Endicott, Prothena's Senior Vice President, Corporate Affairs and Communications. 00:00:25.904 -- 00:00:28.264 Please go ahead. 00:00:29.554 -- 00:00:34.035 Thank you, operator. Good afternoon, everyone, and welcome to Perthena's investor conference 00:00:34.035 -- 00:00:38.856 call to review our business progress, our fourth quarter and full year 2022 financial 00:00:38.856 -- 00:00:44.017 results, and our 2023 financial guidance. Please review the press release we issued 00:00:44.017 -- 00:00:48.557 earlier today, which is available on our website at perthena.com 00:00:48.557 -- 00:00:54.118 and is also attached to a form 8K filed today with the SEC. 00:00:54.118 -- 00:00:59.374 On today's call, Dr. Gene Kinney, our president and chief executive officer, will provide 00:00:59.374 -- 00:01:03.676 introductory remarks followed by an overview of Prathena's portfolio and development 00:01:03.676 -- 00:01:09.438 strategy as we continue advancing toward becoming a fully integrated commercial biotechnology 00:01:09.438 -- 00:01:11.119 company. 00:01:11.119 -- 00:01:16.501 Following Jean's opening remarks, Dr. Hideki Guerin, our Chief Medical Officer, 00:01:16.501 -- ...